Echo Therapeutics, Inc. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Echo Therapeutics, Inc. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of -$128.00 million as of 2014-12-31, per its 10-K filed 2015-04-15.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2015-04-20
- 2014-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$128.00M.
- 2014-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$122.19M; Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed $125.01M.
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $119.51M.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $115.74M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2014-12-31 | -$128.00M 10-K · filed 2015-04-15 | |
| 2014-09-30 | -$122.19M 10-Q · filed 2015-04-20 | $125.01M 10-Q · filed 2014-11-19 |
| 2014-06-30 | $119.51M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $115.74M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $112.97M 10-K · filed 2015-04-15 | |
| 2013-09-30 | $109.47M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $104.23M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $100.89M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $93.90M 10-K · filed 2013-03-18 | |
| 2012-09-30 | $91.97M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $87.71M 10-Q · filed 2012-08-09 |